Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance ...

Daxor Corporation Reports Increase in NAV to $7.08 Per Share and 31.8 Percent Increase in Unaudited Revenue of ...

Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of Diagnostics

Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders

Clinical Account Manager

Daxor Corporation is the global leader in blood volume measurement technology focused on blood volume testing innovation. They are seeking a Clinical Account Manager to manage training, projects, and EHR integration for blood volume testing, requiring extensive travel and collaboration with medical professionals to optimize patient care.

Sign up with Google

Sign in with Google